基础医学与临床 ›› 2022, Vol. 42 ›› Issue (7): 1099-1107.doi: 10.16352/j.issn.1001-6325.2022.07.1099

• 研究论文 • 上一篇    下一篇

SIRT5通过调控ALDH5A1的琥珀酰化促进人乳腺癌细胞的增殖

康有力, 赵丹, 杜文静, 李莉*   

  1. 中国医学科学院基础医学研究所 北京协和医学院基础学院 医学分子生物学国家重点实验室, 北京 100005
  • 收稿日期:2022-04-06 修回日期:2022-05-25 出版日期:2022-07-05 发布日期:2022-06-29
  • 通讯作者: * rene_ll@126.com
  • 基金资助:
    中国医学科学院基本科研业务费(2019-RC-HL-007)

SIRT5 promotes the proliferation of human breast cancer cells by regulating the succinylation of ALDH5A1

KANG You-li, ZHAO Dan, DU Wen-jing, LI Li*   

  1. State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC, Beijing 100005, China
  • Received:2022-04-06 Revised:2022-05-25 Online:2022-07-05 Published:2022-06-29
  • Contact: * rene_ll@126.com

摘要: 目的 利用多种数据库分析SIRT5在泛癌中的表达及与预后的关系并探究SIRT5通过醛脱氢酶5家族成员A1(ALDH5A1)调控乳腺癌增殖的机制。方法 使用cBioPortal、TNMplot、GEPIA与The Kaplan-Meier Plotter等数据库分析SIRT5在多种肿瘤中的基因改变、差异表达及与预后的相关性。利用质谱分析与SIRT5相互作用的蛋白质。使用Metascape对相互作用蛋白质组进行通路富集,并与酰化组学结果进行共分析。通过内外源免疫沉淀(IP)确定SIRT5与ALDH5A1间的相互作用。过表达或敲降SIRT5检测ALDH5A1的酰化水平与酶活改变。通过细胞增殖与克隆实验确定SIRT5与ALDH5A1对乳腺癌增殖的影响。结果 SIRT5在乳腺癌等多种肿瘤中高表达并与不良预后成正相关(P<0.05)。SIRT5相互作用蛋白与酰化组学结果存在多个重叠,并主要富集到氨基酸代谢等代谢通路上。SIRT5与ALDH5A1存在相互作用。SIRT5可通过促进ALDH5A1的去琥珀酰化从而提高其酶活,进而促进乳腺癌细胞增殖(P<0.05)。结论 SIRT5在肿瘤中的功能可能具有异质性,在乳腺癌中可通过ALDH5A1发挥促癌作用,为后续的临床靶向治疗提供理论基础。

关键词: SIRT5, ALDH5A1, 乳腺癌, 增殖

Abstract: Objective To analyze the expression of SIRT5 in pan-cancer and its relationship with prognosis and to explore the mechanism of SIRT5 regulating breast cancer proliferation through aldehyde dehydrogenase 5 family member A1(ALDH5A1). Methods cBioPortal,TNMplot,GEPIA and The Kaplan-Meier Plotter were used to analyze the differential expression of SIRT5 in a variety of tumors and its correlation with prognosis. The interacting proteins co-precipitated with the SIRT5 were analyzed by mass spectrometry. Pathway enrichment was performed for the interaction proteome, and for the combined analysis of the interaction proteome and the acylation proteome. Finally, the ALDH5A1 was focused. Then, the interaction between SIRT5 and ALDH5A1 was determined by an in vivo and in vitro immunoprecipitation(IP).SIRT5 was over-expressed or knocked down to detect acylation level and enzyme activity of ALDH5A1. Finally, the effects of SIRT5 and ALDH5A1 on breast cancer proliferation were determined by cell proliferation and cloning experiments. Results SIRT5 was highly expressed in a variety of tumors such as breast cancer and was positively correlated with poor prognosis (P<0.05). There were multiple overlaps between SIRT5 interacting proteins and acylomics and the overlapped proteins were mainly enriched in metabolic pathways such as amino acid metabolism. SIRT5 directly interacted with ALDH5A1. SIRT5 could enhance the enzyme activity of ALDH5A1 by inducing the desuccinylation of ALDH5A1, thus promoting the proliferation of breast cancer cells (P<0.05). Conclusions The function of SIRT5 in tumors may be specific to a heterogeneous environment and it can play a tumor-promoting role through ALDH5A1 in breast cancer. The results reported here may provide a theoretical basis for subsequent clinical targeted therapy.

Key words: SIRT5, ALDH5A1, breast cancer, proliferation

中图分类号: